• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 211

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Psilocybe Mushroom Pickers in Britain

Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026 Medical Psilocybin Launch; Radial Scores $50M; Otsuka’s “Novel Serotonergic Agonists”; Psilocybin Accelerates Brain...

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy...

Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development...

Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully...

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development...

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker...

Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy...

U.S. FDA Approves Nova Mentis Orphan Drug Application

Cybin Hosting Research and Development Briefing on November 8, 2021

Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct...

1...210211212...304Page 211 of 304

EDITOR PICKS

Psilocybe Mushroom Pickers in Britain

Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026...

The Psychedelic News Feed: December 8 – 14, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©